Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.
about
Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinomaNeu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling.Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.Tissue Factor Pathway Inhibitor-2 Gene Polymorphisms Associate With Coronary Atherosclerosis in Chinese Population.Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.Epigenetics and epigenetic alterations in pancreatic cancer.Induction of Tissue Factor Pathway Inhibitor 2 by hCG Regulates Periovulatory Gene Expression and Plasmin Activity.Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro.Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma.Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
P2860
Q34161719-17BBDD6C-7F41-4C9A-BBC5-167CC3B59ABDQ35145167-5B832BE8-7584-4323-BB14-168C67AB439AQ35378782-80230C1F-4CA7-4D7E-B862-B66F493EFDD5Q35688507-D7A5E53E-3CCD-4F20-9234-96F0CF0263C4Q36156149-B8649B8E-A826-4BEB-9335-7C0851EB2B6AQ36207118-A3BB4515-9126-4754-9FA2-1FE90DCA5E59Q36420282-07B63C31-CFF1-4516-B928-F607DFB4FEF2Q36616250-23265B44-E47F-4758-B00A-D9F8F630F03FQ37041763-EF82BB17-3404-4F39-9BF9-A4D9B7E64FB9Q39215224-A4C368D0-C310-4EF3-AE69-A5E2451EF316Q40481644-945DAB1D-47EA-4105-ABF8-B4666E29F65EQ41779182-05A415B2-69BC-428F-83CE-9D9AAA9BFB68Q41779392-FC6B2071-0C03-44DC-9038-3645358C480BQ42670733-152C0546-4786-4B13-B677-12D8023BF1C5Q54964965-5655E2A3-A9A8-4D2F-B0B8-23C1176258B2
P2860
Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@ast
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@en
type
label
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@ast
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@en
prefLabel
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@ast
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@en
P2093
P2860
P1433
P1476
Tissue factor pathway inhibito ...... oring activated ras oncogenes.
@en
P2093
P2860
P356
10.1016/S0014-5793(00)01902-5
P407
P577
2000-09-01T00:00:00Z